GC
BLUE

Guggenheim Capital’s bluebird bio BLUE Stock Holding History

Guggenheim Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,188
Closed -$1.04M – 2118
2021
Q3 		$1.04M Buy
4,188
+992
+31% +$284K 0.01% 1396
2021
Q2 		$1.32M Sell
3,196
-227
-7% -$89.9K 0.01% 1327
2021
Q1 		$1.34M Buy
3,423
+261
+8% +$129K 0.01% 1246
2020
Q4 		$1.77M Sell
3,162
-194
-6% -$123K 0.01% 1020
2020
Q3 		$2.35M Sell
3,356
-669
-17% -$522K 0.02% 821
2020
Q2 		$3.18M Buy
4,025
+1,409
+54% +$1.06M 0.02% 697
2020
Q1 		$1.56M Sell
2,616
-575
-18% -$560K 0.02% 897
2019
Q4 		$3.63M Buy
3,191
+710
+29% +$772K 0.03% 781
2019
Q3 		$2.95M Sell
2,481
-65
-3% -$99.3K 0.02% 848
2019
Q2 		$4.2M Buy
2,546
+12
+0.5% +$20.8K 0.03% 698
2019
Q1 		$5.16M Sell
2,534
-380
-13% -$669K 0.04% 593
2018
Q4 		$3.75M Buy
2,914
+100
+4% +$153K 0.03% 722
2018
Q3 		$5.32M Buy
2,814
+502
+22% +$1.04M 0.03% 686
2018
Q2 		$4.7M Buy
2,312
+101
+5% +$230K 0.03% 763
2018
Q1 		$4.89M Buy
2,211
+127
+6% +$323K 0.01% 1026
2017
Q4 		$4.81M Sell
2,084
-1,082
-34% -$2.2M 0.01% 1058
2017
Q3 		$5.63M Buy
3,166
+415
+15% +$580K 0.01% 995
2017
Q2 		$3.74M Sell
2,751
-634
-19% -$765K 0.01% 1186
2017
Q1 		$3.98M Sell
3,385
-264
-7% -$269K 0.01% 1161
2016
Q4 		$2.92M Sell
3,649
-279
-7% -$222K 0.01% 1396
2016
Q3 		$3.45M Sell
3,928
-1,922
-33% -$1.39M 0.01% 1245
2016
Q2 		$3.28M Buy
+5,850
New +$3.31M 0.01% 1239
2016
Q1 		– Sell
-6,804
Closed -$5.66M – 2920
2015
Q4 		$5.66M Buy
6,804
+483
+8% +$483K 0.02% 960
2015
Q3 		$7M Buy
6,321
+245
+4% +$447K 0.02% 903
2015
Q2 		$13.3M Sell
6,076
-37
-0.6% -$75.4K 0.03% 735
2015
Q1 		$9.56M Buy
6,113
+1,453
+31% +$1.92M 0.02% 871
2014
Q4 		$5.54M Buy
+4,660
New +$3.11M 0.01% 1072

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Guggenheim Capital's BLUE Position: Q4 2021 in Review

Guggenheim Capital sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 4,188 shares — an estimated $1.04M sold.

Guggenheim Capital first reported a position in BLUE in Q4 2014 and held it in 27 quarters. The position peaked at $13.3M in Q2 2015. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • Guggenheim Capital reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • Guggenheim Capital sold 4,188 bluebird bio shares in Q4 2021, an estimated $1.04M.
  • Guggenheim Capital first reported a position in bluebird bio in Q4 2014 and held it in 27 quarters.
  • Guggenheim Capital's bluebird bio position peaked at $13.3M in Q2 2015.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on Guggenheim Capital's 13F filing for Q4 2021, filed 14 Feb 2022.